Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-582
Closed -$273K 1594
2022
Q2
$273K Buy
+582
New +$284K 0.01% 1153
2022
Q1
Sell
-2,933
Closed -$1.55M 1269
2021
Q4
$1.55M Buy
+2,933
New +$1.41M 0.06% 313
2021
Q3
Sell
-5,800
Closed -$2.75M 1264
2021
Q2
$2.75M Buy
+5,800
New +$2.79M 0.06% 317

Other funds holding CHE

Ergoteles's CHE Position: Q3 2022 in Review

Ergoteles sold out of Chemed (CHE) in Q3 2022, closing a stake of 582 shares — an estimated $273K sold.

Ergoteles first reported a position in CHE in Q2 2021 and held it in 3 quarters. The position peaked at $2.75M in Q2 2021. 419 funds tracked by Wall St. Rank hold CHE as of Q3 2022.

  • Ergoteles reported no remaining Chemed position as of Q3 2022 after selling out during the quarter.
  • Ergoteles sold 582 Chemed shares in Q3 2022, an estimated $273K.
  • Ergoteles first reported a position in Chemed in Q2 2021 and held it in 3 quarters.
  • Ergoteles's Chemed position peaked at $2.75M in Q2 2021.
  • 419 funds tracked by Wall St. Rank held Chemed as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.